Search All News
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
A new study in women found that shortening sleep by just 90 minutes for a few weeks increased insulin resistance, a risk factor for type 2 diabetes.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
- July 19, 2023
Losing weight is often the easy part; keeping it off is usually a struggle. In the POWERS study, Columbia researchers are now delving into the reasons why some people succeed and some fail.
- January 12, 2023
Just five minutes of walking every half hour offsets harmful effects of prolonged sitting, a Columbia University study has found.
- December 1, 2022
Columbia researchers have discovered that a nanomaterial injected into mice shrinks fat at targeted locations, highlighting an unexpected strategy to treat obesity.
- August 29, 2022
A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.
- March 24, 2022
The Nonna's Garden Clinical Diabetes Program will support comprehensive care at Columbia University's Berrie Center.
- February 14, 2022
A study of weight loss methods suggests that gastric bypass surgery is the best strategy for patients with type 2 diabetes and severe obesity, regardless of the severity of a patient’s diabetes.
- December 17, 2021
About half of all new cases of type 1 diabetes occur in older adults but often are misdiagnosed.